High incidence of mild hyponatraemia in females using ecstasy at a rave party

Nephrology Dialysis Transplantation

Volumn 28, Issue 9, 2013, Pages 2277-2283

  Van Dijken, Geetruida D ^a,b   Blom, Renske E ^a   Hené, Ronald J ^a   Boer, Walther H ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Ecstasy; Hyponatriaemia; MDMA

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; HEMOGLOBIN; POTASSIUM; SODIUM;

ADOLESCENT; ADULT; ARTICLE; ASYMPTOMATIC DISEASE; BLOOD SAMPLING; CONTROLLED STUDY; DISEASE PREDISPOSITION; DISEASE SEVERITY; DRUG ABUSE; FEMALE; FLUID INTAKE; HEMATOCRIT; HUMAN; HYPONATREMIA; INCIDENCE; MALE; POLYDIPSIA; POTASSIUM BLOOD LEVEL; PRIORITY JOURNAL; RISK FACTOR; SEX DIFFERENCE; SODIUM BLOOD LEVEL; THIRST; URINALYSIS;

ECSTASY; HYPONATRIAEMIA; MDMA;

ADOLESCENT; ADULT; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; FEMALE; FOLLOW-UP STUDIES; HALLUCINOGENS; HEMOGLOBINS; HUMANS; HYPONATREMIA; INCIDENCE; MALE; MIDDLE AGED; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; NETHERLANDS; POTASSIUM; PROGNOSIS; RECREATION; RISK FACTORS; SODIUM; YOUNG ADULT;

EID: 84880838602     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gft023     Document Type: Article

References (38)

1. Campbell GA, Rosner MH. The agony of ecstasy: MDMA (3, 4-methylenedioxymethamphetamine) and the kidney. Clin J Am Soc Nephrol 2008; 3: 1852-1860
2. Budisavljevic MN, Stewart L, Sahn SA et al. Hyponatraemia associated with 3, 4-methylenedioxymethylamphetamine ('ecstasy') abuse. Am J Med Sci 2003; 326: 89-93
3. Farah R, Farah R. Ecstasy (3, 4-methylenedioxymethamphetamine)-induced inappropriate antidiuretic hormone secretion. Pediatr Emerg Care 2008; 24: 615-617
4. Niemeijer ND, van GC, van WP. Symptomatic hyponatraemia after ecstasy use. Ned Tijdschr Geneeskd 2009; 153: 568-570
5. Ghatol A, Kazory A. Ecstasy-associated acute severe hyponatraemia and cerebral edema: a role for osmotic diuresis? J Emerg Med 2012; 42: e137-40
6. Rosenson J, Smollin C, Sporer KA et al. Patterns of ecstasyassociated hyponatraemia in California. Ann Emerg Med 2007; 49: 164-71, 171
7. Cherney DZ, Davids MR, Halperin ML. Acute hyponatraemia and 'ecstasy': insights from a quantitative and integrative analysis. QJM 2002; 95: 475-483
8. Netherlands National Drug Monitor, Annual Report 2010, page 125, www.trimbos.nl/webwinkel article number AF1106 2012
9. Forsling ML, Fallon JK, Shah D et al. The effect of 3, 4-methylenedioxymethamphetamine (MDMA, 'ecstasy') and its metabolites on neurohypophysial hormone release from the isolated rat hypothalamus. Br J Pharmacol 2002; 135: 649-656
10. Fallon JK, Shah D, Kicman AT et al. Action of MDMA (ecstasy) and its metabolites on arginine vasopressin release. Ann N Y Acad Sci 2002; 965: 399-409
11. Simmler LD, Hysek CM, Liechti ME. Sex differences in the effects of MDMA (ecstasy) on plasma copeptin in healthy subjects. J Clin Endocrinol Metab 2011; 96: 2844-2850
12. Parrott AC, Lock J, Conner AC et al. Dance clubbing on MDMA and during abstinence from Ecstasy/MDMA: prospective neuroendocrine and psychobiological changes. Neuropsychobiology 2008; 57: 165-180
13. Brvar M, Kozelj G, Osredkar J et al. Polydipsia as another mechanism of hyponatraemia after 'ecstasy' (3, 4 methyldioxymethamphetamine) ingestion. Eur J Emerg Med 2004; 11: 302-304
14. Ben-Abraham R, Szold O, Rudick V et al. 'Ecstasy' intoxication: life-threatening manifestations and resuscitative measures in the intensive care setting. Eur J Emerg Med 2003; 10: 309-313
15. Morgenthaler NG, Struck J, Alonso C et al. Assay for the measurement of copeptin, a stable peptide derived from the precursor of vasopressin. Clin Chem 2006; 52: 112-119
16. Liechti ME, Gamma A, Vollenweider FX. Gender differences in the subjective effects of MDMA. Psychopharmacology (Berl) 2001; 154: 161-168
17. Rose BD, Post TW. Hypoosmolal states-hyponatraemia. Clinical Physiology of Acid-Base and Electrolyte Disorders. 5th edn. New York: McGraw-Hill; 2001 pp. 716-720
18. Ayus JC, Wheeler JM, Arieff AI. Postoperative hyponatremic encephalopathy in menstruant women. Ann Intern Med 1992; 117: 891-897
19. Ayus JC, Varon J, Arieff AI. Hyponatraemia, cerebral edema, and noncardiogenic pulmonary edema in marathon runners. Ann Intern Med 2000; 132: 711-714
20. Ayus JC, Arieff AI. Pulmonary complications of hyponatremic encephalopathy. Noncardiogenic pulmonary edema and hypercapnic respiratory failure. Chest 1995; 107: 517-521
21. Kalantar-Zadeh K, Nguyen MK, Chang R et al. Fatal hyponatraemia in a young woman after ecstasy ingestion. Nat Clin Pract Nephrol 2006; 2: 283-8
22. Stachenfeld NS, Splenser AE, Calzone WL et al. Sex differences in osmotic regulation of AVP and renal sodium handling. J Appl Physiol 2001; 91: 1893-1901
23. Klaestrup E, Trydal T, Pedersen JF et al. Reference intervals and age and gender dependency for arterial blood gases and electrolytes in adults. Clin Chem Lab Med 2011; 49: 1495-1500
24. Fraser CL, Arieff AI. Epidemiology, pathophysiology, and management of hyponatremic encephalopathy. Am J Med 1997; 102: 67-77
25. Speedy DB, Noakes TD, Schneider C. Exercise-associated hyponatraemia: a review. Emerg Med (Fremantle) 2001; 13: 17-27
26. Grikiniene J, Volbekas V, Stakisaitis D. Gender differences of sodium metabolism and hyponatraemia as an adverse drug effect. Medicina (Kaunas) 2004; 40: 935-942
27. Forsling ML, Stromberg P, Akerlund M. Effect of ovarian steroids on vasopressin secretion. J Endocrinol 1982; 95: 147-151
28. Stachenfeld NS, Silva C, Keefe DL et al. Effects of oral contraceptives on body fluid regulation. J Appl Physiol 1999; 87: 1016-1025
29. Juul KV, Klein BM, Sandstrom R et al. Gender difference in antidiuretic response to desmopressin. Am J Physiol Renal Physiol 2011; 300: F1116-F1122
30. Liu J, Sharma N, Zheng W et al. Sex differences in vasopressin V (2) receptor expression and vasopressin-induced antidiuresis. Am J Physiol Renal Physiol 2011; 300: F433-F440
31. Ayus JC, Arieff AI. Chronic hyponatremic encephalopathy in postmenopausal women: association of therapies with morbidity and mortality. JAMA 1999; 281: 2299-2304
32. Ayus JC, Achinger SG, Arieff A. Brain cell volume regulation in hyponatraemia: role of sex, age, vasopressin, and hypoxia. Am J Physiol Renal Physiol 2008; 295: F619-F624
33. http://www.emcdda.europa.eu/html.cfm/index61221EN.html. 2012. Ref Type: Generic
34. Wolff K, Tsapakis EM, Winstock AR et al. Vasopressin and oxytocin secretion in response to the consumption of ecstasy in a clubbing population. J Psychopharmacol 2006; 20: 400-410
35. UNODC, World Drug Report 2010 (United Nations Publication, Sales No. E.10.XI.13). 2011. Ref Type: Generic
36. Kolbrich EA, Goodwin RS, Gorelick DA et al. Plasma pharmacokinetics of 3, 4-methylenedioxymethamphetamine after controlled oral administration to young adults. Ther Drug Monit 2008; 30: 320-332
37. Burke LM. Nutritional needs for exercise in the heat. Comp Biochem Physiol A Mol Integr Physiol 2001; 128: 735-748
38. Von Duvillard SP, Braun WA, Markofski M et al. Fluids and hydration in prolonged endurance performance. Nutrition 2004; 20: 651-656